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ABSTRACT
The microRNA (miRNA)-mediated repression of
protein synthesis in mammalian cells is a reversible
process. Target mRNAs with regulatory AU-rich
elements (AREs) in their 30-untranslated regions
(30-UTR) can be relieved of miRNA repression
under cellular stress in a process involving the
embryonic lethal and altered vision family ARE-
binding protein HuR. The HuR-mediated derepres-
sion occurred even when AREs were positioned at a
considerable distance from the miRNA sites raising
questions about the mechanism of HuR action.
Here, we show that the relief of miRNA-mediated
repression involving HuR can be recapitulated in
different in vitro systems in the absence of stress,
indicating that HuR alone is sufficient to relieve the
miRNA repression upon binding to RNA ARE. Using
in vitro assays with purified miRISC and recombin-
ant HuR and its mutants, we show that HuR, likely by
its property to oligomerize along RNA, leads to the
dissociation of miRISC from target RNA even when
miRISC and HuR binding sites are positioned at a
distance. Further, we demonstrate that HuR associ-
ation with AREs can also inhibit miRNA-mediated
deadenylation of mRNA in the Krebs-2 ascites
extract, in a manner likewise depending on the
potential of HuR to oligomerize.
INTRODUCTION
MicroRNAs (miRNAs) are 21-nt-long non-coding
RNAs acting as post-transcriptional regulators of gene
expression in eukaryotes. In mammals, hundreds of differ-
ent miRNAs are expressed and they are predicted to
control the activity of 50% of all genes. Thus,
miRNAs regulate most of the investigated developmental
and cellular processes and their altered expression is
observed in many human pathologies, including cancer
(1–5).
In metazoa, miRNAs regulate gene expression by base
pairing to target messenger RNAs (mRNAs), bringing
about their translational repression and/or deadenylation,
which leads to mRNA degradation. Generally, miRNAs
base pair imperfectly with sequences in mRNA
30-untranslated regions (30-UTRs), where positions 2–8
of the miRNA, referred to as a seed sequence, are most
important for this association. However, some miRNAs
base pair with perfect or nearly perfect complementarity
and induce endonucleolytic cleavage of mRNA by an
RNA interference (RNAi) mechanism, similar to that
mediated by short interfering RNAs (siRNAs) (1,6–9).
miRNAs function in the form of ribonucleoprotein
particles, miRNPs or miRISCs (miRNA-induced silencing
complexes). Argonaute (Ago) proteins are the best-
characterized essential components of miRISC and four
Ago proteins, Ago1 through Ago4, all directly associate
with miRNAs in mammals and function in the repression.
Of the four mammalian Ago proteins, only Ago2 is
catalytically competent to endonucleolytically cleave the
target RNA. GW182 proteins are additional important
components of miRISC. They associate with Ago
proteins and function as effectors in the repression (8,9).
Until recently, miRNAs were identiﬁed primarily as
negative regulators of cellular mRNAs and it was not
known whether the inhibition of a particular mRNA can
be effectively reversed. The ability to disengage miRNAs
from the repressed mRNA, or render them inactive, would
result in miRNA regulation being more dynamic and
more responsive to speciﬁc cellular events. Indeed, it was
found recently that miRNA repression of different
mRNAs can be strongly modulated or even reversed by
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factors as diverse as cellular stress, developmental cues or
neuronal stimulation (10–27). Moreover, miRNAs in cell
cycle-arrested cells were found to activate rather than
repress translation of selected mRNA targets (28–30).
Many of these reports document a crucial role for
RNA-binding proteins (RBPs) in modulating miRNA
function. Hundreds of different RBPs are expressed in
metazoan cells and dozens of them are known to
interact, like miRNAs, with mRNA 30-UTRs and
regulate mRNA expression and stability (31). Since
30-UTRs of mammalian mRNAs can be as long as 10 or
more kilobases and can associate with many different
miRNAs and RBPs, these ﬁndings indicated a potentially
very complex interplay between the two classes of
regulators interacting with the 30-UTR (23,24).
Previously, we demonstrated that CAT-1 mRNA that
encodes the high-afﬁnity cationic amino acid transporter
and which is translationally repressed by miR-122 in
human Huh7 hepatoma cells, can be relieved of inhibition
by subjecting cells to various stress conditions. We also
found that the stress-induced alleviation of miR-122
repression requires the binding to the CAT-1 mRNA
30-UTR of HuR, an RBP known to interact with
AU-rich elements (AREs) (11). Reporter RNAs bearing
sites targeted by let-7 miRNA showed regulation similar
to that of CAT-1 mRNA and reporters bearing the CAT1
30-UTR (11). HuR is an ubiquitously expressed member of
the embryonic lethal and altered vision (ELAV) family of
proteins, which also includes three neuron-speciﬁc
proteins, HuB, HuC and HuD (32–34). HuR consists of
three RNA-binding RRM domains, with RRM1 and
RRM2 together being responsible for binding to the
ARE. HuR and other members of the ELAV family
have the potential to oligomerize along RNA and a
hinge region separating RRM2 and RRM3, and RRM3
of ELAV proteins were shown to be important for this
process (35–40). Although HuR is predominantly a
nuclear protein, it shuttles between the nucleus and the
cytoplasm and the hinge region is essential for shuttling
and nuclear accumulation of the protein (41). In response
to different types of cellular stress, HuR translocates
from the nucleus to the cytoplasm, where it modulates
the translation and/or stability of many mRNAs
(34,42,43).
Although the role of HuR in the reversal of miRNA
repression of CAT-1 mRNA as well as its function in
modulating miRNA-mediated repression of other
mRNAs, is well documented (11,12,17,21,22), the mech-
anism of these HuR effects has not been established.
Likewise, it is not known whether factors other than
HuR, possibly induced in cells subjected to stress, partici-
pate in the process. In the present study, we have used
recombinant HuR and its mutants, and puriﬁed miRISC
to study the derepression process in vitro.
MATERIALS AND METHODS
Expression plasmids
Plasmids expressing FLAG-HA-Ago1, FLAG-HA-Ago2
and the FLAG-HA tagging vector were obtained
from G. Meister (44). Myc-Ago2, Ago2D669A and
Ago2H634A mutant clones were generously provided by
G. Hannon (45). Full-length cDNAs-encoding mutant
Ago2 were ampliﬁed from Myc-Ago2 plasmids and
subcloned into FLAG-HA tagging vector between NotI
and EcoRI sites. pLET7a encoding pri-let-7a was kindly
provided by J. Belasco (46). For expression of HuR and
mutant proteins [HuRH: hinge region (H) (amino acids
186–242) deleted; HuR3: RRM3 (amino acids 243–326)
deleted; and HuRH3: both hinge and RRM3 (amino
acids 186–326) deleted] in Escherichia coli, appropriate
regions were PCR ampliﬁed from plasmids kindly
provided by A. B. Shyu (47) and the inserts were cloned
in pET42a(+) (Novagen) between NdeI and XhoI sites for
His-tag puriﬁcation. Plasmids HA-Ago3 (48) and
HA-TNRC6B (49) were described before. Primers for
ampliﬁcation are presented in Supplementary Table S1.
Correctness of all plasmids was conﬁrmed by sequencing.
Puriﬁcation of His6-HuR fusion proteins
Overnight cultures of E. coli BL21, transformed with
plasmids expressing HuR or its mutants were diluted at
1:200 with the LB medium. At A600 of 0.3, cultures were
induced with IPTG (0.1mM) and grown overnight at
18C. Cells were spun down and lysed in buffer containing
20mM Tris–HCl, pH 7.5, 300mM KCl, 2mM MgCl2,
5mM b-mercaptoethanol (b-me), 50mM imidazole,
0.5% Triton X-100, 5% glycerol, 0.5mg/ml lysozyme,
1EDTA-free Protease Inhibitor Cocktail (Roche).
The lysate was centrifuged at 16 000g for 30min at 4C.
The supernatant was incubated with Ni-NTA Agarose
beads (Qiagen) for 2 h at 4C. After washing the beads
with buffer A (20mM Tris–HCl, pH 7.5, 150mM KCl,
2mM MgCl2, 5mM b-me, 100mM imidazole, 0.5%
Triton X-100, 2.5% glycerol) and buffer B (as buffer A
but containing 250mM imidazole), each for 15min at 4C,
protein was eluted with buffer C (as buffer A but contain-
ing 500mM imidazole, 5% glycerol and 1EDTA-free
Protease Inhibitor Cocktail (Roche). The eluted protein
was dialyzed against storage buffer (20mM Tris–HCl,
pH 7.5, 200mM KCl, 2mM MgCl2, 1mM DTT, 0.1%
Triton X-100, 5% glycerol and EDTA-free Protease
Inhibitor Cocktail) and stored at 80C . To avoid pre-
cipitation, concentration of recombinant proteins was
kept below 3 mM.
Puriﬁcation of miRISC
MiRISC complexes, preferentially loaded with let-7a
miRNA, were puriﬁed from HEK293T cells (grown in
10 cm dish) doubly transfected with plasmids (5 mg each)
expressing pri-let-7a and indicated FLAG-HA-tagged
Ago proteins or their mutants. Forty-eight hours after
transfection, cells were lyzed in 1ml of 50mM Tris–HCl,
pH 7.4 containing 150mM NaCl, 1mM EDTA and 0.5%
Triton X-100. After centrifugation at 14 000g, the super-
natant was used for IP puriﬁcation with 40 ml anti-FLAG
M2 Afﬁnity Gel (Sigma). The miRISC complex was eluted
with 3xFLAG peptide (Sigma), following the manufac-
turer’s protocol.
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Concentration of active Ago2-miRISC was determined
as described in ref. (50). In brief, the cleavage of labeled
target RNA present in excess was quantiﬁed in a time
course, the amount of product (y-axis) was plotted
against time (x-axis), and slower steady-state cleavage
rate line was extrapolated back to y-axis. The y-intercept
at the zero time point denoted the amount of active
miRISC. Since concentration of Ago2-mutant- and also
Ago1-containing puriﬁed miRISCs could not be measured
by the cleavage assay, calculation of their amounts
was based on western analysis and comparison with the
Ago2 miRISC (Figure 5A).
Generation of templates for in vitro transcription
Templates for generation of HBS_20_MBSp, HBS_20_
MBSp and HBSMut_20_MBSp target RNAs were
prepared by annealing synthetic antisense DNA oligo-
nucleotides (Microsynth; for sequences, see Supple-
mentary Table S2) to the T7 promoter sense
oligonucleotode (T7s; Supplementary Table S2). Mixture
of oligonucleotides, each 50 mM, was heated at 95C for
3min in 1 annealing buffer (10mM Tris–HCl, pH 8.0,
100mM NaCl, 0.1mM EDTA) and then allowed to
slowly cool down to room temperature.
For synthesis of HBS_50_MBSp, HBS_50_MBSb
and MBSb_50_HBS target RNAs, double-stranded
DNA templates were used. The templates were prepared
by annealing equimolar amounts of two oligonucleotides
(T7s and 50-phosphorylated sense; Supplementary Table
S2) forming a sense strand with two oligonucleotides
(reverse and 50-phosphorylated antisense; Supplementary
Table S2) forming an antisense (template) strand, followed
by ligation by T4 DNA ligase (NEB). The resulting
double-stranded products were used as templates for
PCR ampliﬁcation with T7s and reverse oligonucleotides
as primers, gel puriﬁed and used as templates for in vitro
transcription.
In vitro transcription, RNA labelling, and DNA and
LNA oligonucleotide annealing
MBSp and MutMBSp substrate RNAs were purchased
from Dharmacon RNA Technologies. For other target
RNAs, transcription reactions (50ml), containing 1 tran-
scription buffer (Promega), 500 mM each ATP, CTP and
UTP, 200mM GTP, 3.5mM guanosine, 1.25mM MgCl2,
2.5mM DTT, 40 U of RNase Out (Invitrogen) and 300 U
of T7 RNA polymerase (Epicenter Biotechnologies), were
performed at 37C for 3 h with 200 nM of template.
Inclusion of excess of guanosine, compared to GTP,
resulted in its incorporation at the RNA 50-end, thus
making the 50-end dephosphorylation step unnecessary
(51). Sequences of RNA transcripts are shown in
Supplementary Table S3. The transcripts were analyzed
by 10% polyacrylamide/8M urea PAGE, excised, eluted
from the gel with 0.3M sodium acetate (pH 5.2), 0.5mM
EDTA and 0.1% SDS, precipitated, dissolved in water
and stored at 80C. When indicated, the transcripts
were 50-end-labeled, using T4 polynucleotide kinase
(NEB) and [g-32P] ATP (5000Ci/mmol; Hartmann
Analytic) according to manufacturer’s protocol.
Following labelling, transcripts were subjected to column
puriﬁcation (Micro Bio-Spin 30 Columns, RNase-free;
Bio-Rad Laboratories), precipitated and stored at
20C in water before use.
For annealing of HBS_50_MBSp RNA to a 50-mer
DNA (complementary to the entire spacer) or 27-mer
LNA oligonucleotide (complementary to the region
starting from 4th nt of the spacer), they were mixed at
the RNA to oligonucleotide ratio of 1:3, heated at 95C
for 3min in 1 annealing buffer (10mMTris–HCl, pH 8.0,
100mMNaCl), followed by slow cooling to room tempera-
ture. Annealing of HBS_20_MBSp to 20-mer LNA oligo-
nucleotide sequence (complementary to the entire spacer)
was done in a similar way. The sequences of oligonucleo-
tides are given in Supplementary Table S4.
Target RNA cleavage assay
The reactions (10 ml), containing 1 cleavage buffer
(20mM HEPES-KOH, pH 7.4, 150mM KCl, 2mM
MgCl2, 0.01% Triton X-100, 5% glycerol, 1mM DTT),
0.1 mg yeast tRNA, puriﬁed miRISC (0.2 nM), 50-end
labeled target RNA (0.1 nM) and increasing amounts of
indicated HuR proteins, were incubated for 15min at
30C. Reactions were stopped by adding urea stop dye
(8M urea, 50mM EDTA, 0.04% bromophenol blue,
0.04% xylene cyanol), followed by heating at 95C
for 2min. The products were analyzed by 8M urea
PAGE. Reaction products were quantiﬁed using a
PhosphorImager (Molecular Dynamics, Inc). For
analysis of the effect of HuR on cleavage of target RNA
containing pre-bound miRISC, the 1 cleavage buffer
initially contained 5mM EDTA in place of MgCl2. At
the indicated time point, MgCl2 was added to the ﬁnal
5mM concentration.
For quantiﬁcation of cleavage reactions, the radioactiv-
ity present in bands corresponding to cleaved (RC)
and uncleaved (RU) RNA in each lane was measured
using ImageQuant v5.2 (Molecular Dynamics, Inc). The
degree of cleavage was always calculated as a fraction of
radioactivity present in RC band compared to the total
measured radioactivity [RC/ (RC+RU)]. The values for
reactions containing increasing concentrations of HuR
or its mutants were normalized to values obtained in
the absence of HuR which were set to 1.
Electrophoretic mobility shift assays
Interactions of HuR and its mutants with target RNAs
were analyzed by electrophoretic mobility shift assays
(EMSA), using non-denaturing gels. The reactions
(10 ml) contained 1 cleavage buffer, 1 mg of yeast
tRNA, 2 fmol of 50-32P-labeled RNA, and indicated
increasing concentrations of puriﬁed proteins. Following
10min incubation on ice, the reactions were immediately
processed for a non-denaturing 6% PAGE performed at
4C. The gel was dried and the resolved RNA:protein
complexes were visualized by phosphorimaging.
Analysis of miRISC association with target RNA
For measurements of miRISC association with target
RNA, the puriﬁed miRISC was immobilized on
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a-FLAG beads and then ﬁrst incubated with target RNA,
followed by addition of HuR (see scheme in Figure 5B).
A 30 ml a-FLAG M2 Afﬁnity Gel beads (Sigma)
were pre-incubated with 4 ml of puriﬁed miRISC in 1ml
of binding buffer [50mM Tris–HCl, pH 7.4, 150mM
NaCl, 1EDTA-free Protease Inhibitor Cocktail
(Roche)]. The beads were spun down and resuspended in
100 ml of the binding buffer additionally containing
50 fmol of target RNA, 1 mg tRNA, 0.5mM DTT and
5mM EDTA (in a case of the Ago2 miRISC) or 2mM
MgCl2 (in a case of other catalytically inactive miRISCs).
Samples were incubated for 15min at 23C, followed by
additional 15min incubation at 23C in the presence or
absence of 150 nM of HuR. The beads were spun down by
centrifugation at 5000g for 1min and washed twice with
binding buffer. The RNA bound to beads was extracted
with TRIzol reagent (Invitrogen), reverse transcribed
using a reverse primer (GCTCATCAGATGTTGAGT
CC; complementary to the 30-end of the spacer region)
and 25 U of Superscript III RT (Invitrogen). One-fourth
of the RT reaction was then used for quantitative
real-time PCR (RT-qPCR), using the ABI 7500 Fast
Sequence Detection System (Applied Biosystems) and
Platinum SYBR Green qPCR Super Mix (Invitrogen).
Sequence of the forward PCR primer for
HBS_50_MBSp and HBS_50_MBSb are GGTATTTAT
TTATTTATTTGTTTG and that for MBSb_50_HBS is
GGTCCAAAGAGTGACTGCACAGCC. The reverse
primer was the same as that used for RT.
RNA deadenylation assay
Plasmids used in the synthesis of RNAs tested in
deadenylation assays were prepared by inserting the
AU-rich downstream (ARD) region from the 30-UTR of
human CAT-1 mRNA (11) into the NotI site downstream
of the 6xB and 6xBMut sequences of RL-6xB-pA and
RL-6xBMut-pA (52) to generate RL-6xB-ARD-pA and
RL-6xBMut-ARD-pA, respectively. The sequences of
primers are given in Supplementary Table S1. The
preparation of all internally labeled RNAs by in vitro
transcription and the assay were performed as previ-
ously described (53). Quantiﬁcation of deadenylation
reactions was performed similarly to the quantiﬁca-
tion of cleavage reactions described above. The percentage
of deadenylation was always calculated as a fraction
of radioactivity present in the band corresponding to
poly(A) RNA compared to the amount of radioactivity
corresponding to the sum of poly(A) and poly(A)+
RNAs [pA/(pA++pA)] present in each lane.
RESULTS
Recombinant HuR inhibits cleavage of RNA by
miRISC in vitro
To investigate whether it is possible to recapitulate
the HuR-mediated alleviation of miRNA repression
in vitro, using puriﬁed components, we ﬁrst used the
miRISC-mediated cleavage assay. miRISC bearing Ago2
as an effector protein, endonucleolytically cleaves target
RNAs, which contain sites perfectly complementary to
miRNA (44,45). The let-7-miRNA-enriched miRISC was
prepared by the co-expression of human FLAG-HA-
tagged Ago2 and let-7a primary precursor (pri-miRNA)
in HEK293T cells, followed by afﬁnity puriﬁcation on
anti-FLAG antibody beads. In HEK293T cells, let-7
RNAs are expressed only at a relatively low level (54)
that allows for enrichment of the FLAG-tagged miRISC
in this speciﬁc miRNA. The expression of tagged Ago2
was veriﬁed by western blotting (Supplementary Figure
S1A) and functionality of the puriﬁed miRISC was
ascertained by incubating it with the 50-32P-labeled
model RNA substrates bearing one perfectly complemen-
tary let-7 site (MBSp) or its mutated version (MutMBSp)
(Supplementary Figure S1B). Only miRISC enriched in
the co-expressed let-7 miRNA catalyzed target RNA
cleavage and the cleavage was dependent on the
presence of a fully complementary site (Supplementary
Figures S1C and S1D).
We tested whether addition of puriﬁed recombinant
HuR, bacterially expressed as a His-tag fusion
(Figure 1A), affects miRISC-mediated cleavage of RNA
containing the let-7 MBSp and the HuR-binding site
[HBS; a high-afﬁnity AU-rich element (ARE) originating
from IL-1b mRNA; (55)] positioned upstream
(Figure 1B). As shown in Figure 1C and E, addition of
HuR resulted in the concentration-dependent repression
of cleavage of substrates containing HBS and MBS
elements. Since a similar effect was seen with RNAs
bearing the elements either 20 nt (HBS_20_MBSp) or
50 nt (HBS_50_MBSp) apart, it is unlikely that binding
of HuR to HBS caused a direct steric hindrance of
miRISC association. HuR had no effect on cleavage
of RNAs bearing mutated HBS or having no HBS
(Figure 1D and E). The latter two substrates also did
not bind HuR, as assessed by a native gel EMSA (data
not shown). Unless indicated otherwise, all target RNA
cleavage assays were incubated for 15min to stay within a
linear range of the reaction (Supplementary Figure S2).
This was particularly important when effects of HuR
and its mutants on the miRISC-mediated cleavage
were compared (see below).
HuR oligomerization mutants are defective in
attenuating miRISC cleavage
HuR and related proteins, such as HuB, HuD and
Drosophila ELAV, are known to oligomerize along
RNA substrates (35–40). Furthermore, for HuR and
Drosophila ELAV, the hinge separating RRM2 and
RRM3, and the RRM3 were identiﬁed as domains
contributing to the formation of cooperative HuR–RNA
complexes (36,40). We investigated whether HuR oligo-
merization might play a role in miRISC interference
of RNA cleavage. To this end, we have puriﬁed three
different HuR mutants: HuRH (devoid of a hinge
region separating RRM2 and RRM3), HuR3 (RRM3
deleted) and HuRH3 (missing both the hinge
region and RRM3) (Figure 2A and B). Consistent
with previous ﬁndings (36,40), a full-length HuR, and
HuRH and HuR3 mutants formed complexes with
HBS_50_MBSp RNA, gradually increasing in size in
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a concentration-dependent manner. In contrast, the po-
tential of HuRH3 to oligomerize was clearly diminished
as seen in Supplementary Figure S3 (36). We then
compared activity of different HuR mutants to interfere
with the miRISC function. Interestingly, the two mutants
able to oligomerize, HuRH and HuR3, inhibited
miRISC-mediated cleavage of HBS_50_MBSp RNA,
although at a concentration higher than the full-length
HuR. In contrast, the cleavage of target RNA remained
unaffected in the presence of the mutant HuRH3,
which is defective in oligomerization (Figure 2C and D).
To obtain additional evidence that HuR oligomeriza-
tion may be important for interference with the
miRISC-mediated target cleavage, we tested the effect of
pre-hybridizing the oligonucleotides complementary to the
spacer separating HBS and MBSp sequences in the target
RNA. Hybridization of a 50-nt-long oligodeoxynucleotide
complementary to the entire spacer of the HBS_50_MBSp
RNA or a 27-mer oligonucleotide bearing several LNA
nucleotides (Figure 3A) and forming a duplex of stability
comparable to that formed with the 50-mer DNA
oligonucleotide, almost entirely eliminated the inhibitory
effect of HuR on RNA cleavage by miRISC (Figure 3B).
Similar result was obtained with HBS_20_MBSp RNA,
having the 20-nt-long spacer separating HBS and MBSp
sites. Annealing of the 20-mer LNA oligonucleotide
complementary to the HBS_20_MBSp spacer completely
eliminated the effect of HuR (Supplementary Figure S4).
We have veriﬁed that hybridization of complementary
50-mer DNA oligonucleotide to the HBS_50_MBSp
RNA strongly reduced a potential of the duplex to form
multimeric complexes with HuR, as analyzed by EMSA
(Figure 3C). It was also noted that the IL-1b HBS element
is 33-nt long and probably able to accommodate two HuR
molecules, either monomers or dimers (36,56). Incubation
of HuR with duplexes of HBS_50_MBSp RNA and LNA
oligonucleotide resulted in formation of complexes that
did not enter the non-denaturing gel, thus preventing
analysis of the LNA effect on HuR oligomerization by
EMSA (data not shown).
Taken together, these results indicate that the oligomer-
ization potential of HuR along target RNA may be
important for the protein interference with miRISC
activity.
HuR can displace miRISC pre-bound to the target RNA
In the experiments described so far, miRISC and HuR
were always mixed together prior to addition of target
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Figure 1. Puriﬁed recombinant HuR speciﬁcally inhibits RNA cleavage mediated by the let-7 miRISC. (A) Coomassie blue-stained SDS–
polyacrylamide gel showing purity of the recombinant full-length HuR. Lane M, protein size markers (in kDa). (B) Schemes of target RNAs
used for the cleavage assay. HBS, HuR Binding Site; MBS, miRNA Binding Site; HBS and HBS Mut, HBS deleted or mutated. ‘p’ denotes perfect
let-7 complementarity of the MBS site. (C and D) Representative in vitro cleavage reactions performed with different 50-32P-labeled target RNAs and
increasing indicated concentrations of HuR. ‘Inp’ denotes input 50-32P-labeled RNA substrate. The cleavage product is indicated by an arrow.
(E) PhosphorImaging quantiﬁcation of cleavage reactions similar to those shown in panels C and D. Values (means±SD; n 3) were normalized
to the reactions in the absence of HuR.
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mRNA. We investigated whether the addition of HuR can
inhibit miRISC or dissociate it from the target even when
it has been pre-bound to the RNA. First, we tested the
effect of HuR addition on the cleavage activity of miRISC
pre-incubated with target RNAs. Pre-incubation of
miRISC with either HBS_20_MBSp or HBS_50_MBSp
was performed in the presence of EDTA to inhibit
Mg2+-dependent cleavage of RNAs containing perfectly
complementary let-7 sites. Following a 10-min incubation
at 30C, Mg2+ and HuR were added and the incubation
continued initially at 4C (to inhibit miRISC cleavage but
to allow HuR binding) and then at 30C (Figure 4A). We
have veriﬁed that inclusion of EDTA or incubation at 4C
effectively prevents substrate RNA cleavage by miRISC
(Figure 4A and B, conditions A1 and A2). Importantly, as
shown in Figure 4B and C, inclusion of HuR led to
concentration-dependent inhibition of target cleavage,
indicating that HuR can interfere with the activity of
miRISC pre-bound to RNA. The observed effect was de-
pendent on the presence of functional HuR-binding site
since addition of HuR had no effect on activity of miRISC
pre-bound to RNA bearing either mutated HBS or having
no HBS (Figure 4B and C).
To determine directly whether HuR is able to displace
miRISC bound to the target, we measured the association
of the HBS_50_MBSp RNA with miRISC following
the HuR addition. In addition to the miRISC containing
a wild-type (wt) Ago2, we also used miRISCs in which
let-7 is loaded onto FLAG-HA-Ago1 or FLAG-HA-
tagged Ago2 mutants Ago2D669A and Ago2H634A
(Figure 5A, left panel), which like Ago1 are catalytically
inactive [(45), Figure 5A, right panel)]. Pre-binding of the
wt-Ago2 miRISC was carried out in the presence of
EDTA but pre-binding of the three remaining catalytically
incompetent miRISCs was performed in the presence
of Mg2+. Following incubation with HuR, the amount
of HBS_50_MBSp RNA remaining associated with
the immobilized miRISC was quantiﬁed by real-time
PCR (RT-qPCR) (Figure 5B). We found that addition
of HuR decreased by 2- to 3-fold the association of
HBS_50_MBSp RNA with all tested miRISC variants,
consistent with HuR-mediated dislocation of miRISC
from the RNA target (Figure 5C).
HuR can effectively displace miRISC from target
RNAs bearing a bulged miRNA site
We also tested the effect of HuR addition on the associ-
ation of the Ago2-miRISC with targets containing the
let-7 site, which is not complementary to let-7 RNA in
its central region [‘bulged’ let-7 site, identical to that
used in RL-3xB reporters responding to let-7 miRNA.
Reporters bearing these sites and also HuR-binding
AREs were shown previously to be relieved from the
let-7-mediated repression in cells subjected to stress (11)].
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Figure 2. Activity of different HuR mutants in alleviating miRISC cleavage. (A) Schemes of wt HuR and its deletion mutants. (B) Coomassie
blue-stained SDS–polyacrylamide gel showing puriﬁcation of different HuR mutant HuR. Lane M, protein size markers (in kDa). (C) Representative
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HBS and MBS sites prevent the HuR effect on miRISC cleavage
in vitro. (A) Schemes of the HBS_50_MBSp target RNA hybridized
to complementary 50-mer DNA and 27-mer LNA oligonucleotides.
(B) Prehybridization of DNA and LNA oligonucleotides interferes
with the alleviating effect of HuR on miRISC cleavage. (Upper
panels) Effect of increasing concentrations of HuR on cleavage of
control HBS_50_MBSp RNA or its duplexes with either DNA or
LNA oligonucleotides. (Lower panel) Quantiﬁcation (means±SD;
n=3) of experiments similar to those shown in upper panels. (C)
Prehybridization of 50-nt DNA oligonucleotide complementary to the
spacer region of HBS_50_MBSp RNA interferes with HuR oligomer-
ization along RNA as visualized by EMSA. Although comparison of
the left (no oligonucleotide) and right (complementary oligonucleotide
added) panels reveals the decrease in a number of HuR-associated
bands in response to hybridizing the oligonucletide, the precise
number and nature of HuR molecules associated with each EMSA
band is difﬁcult to assign. The IL-1b HBS element itself is 33-nt long
and is likely to accommodate two HuR molecules; in addition, HuR
may associate with RNA as either monomer or homodimer (36,56).
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Figure 4. HuR inhibits cleavage by the miRISC pre-bound to RNA.
(A) Overview of the experimental set up for cleavage assay with
miRISC pre-bound to target RNA. RNA was pre-bound to miRISC
for 10min in the presence of EDTA to ensure blocking of the cleavage
(time-point A1), followed by incubation on ice for 5min (time-point A2)
after simultaneous addition of HuR and Mg2+. The cleavage reaction
was incubated for 15min at 30C. (B) Representative in vitro cleavage
reactions of HBS_20_MBSp and HBS_50_MBSp RNAs (upper panels)
and HBS_20_MBSp and MutHBS_20_MBSp RNAs (lower panels),
as a function of increasing concentration of HuR. Reactions followed
the experimental set up presented in A. The RNA remains uncleaved
when incubated with miRISC in the presence of EDTA at 30C (lane
A1) or upon addition of Mg
2+ when the incubation is performed on ice
(lane A2). (C) Quantiﬁcation of reactions similar to the one shown in B
(mean±SD; n=3).
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The two RNA targets analyzed by us, HBS_50_MBSb and
MBSb_50_HBS, differ in the relative orientation of HBS
and MBSb sites in RNA (Figure 5D, left panel). Inclusion
of HuR decreased the association of targets with both wt
(Ago2 and Ago1) and mutant (Ago2D669A) miRISCs by
10-fold. This effect was independent of the orientation
of MBSb and HBS sites and, most signiﬁcantly, was
not observed when the non-oligomerizing HuR mutant
HuRH3 was used instead of the wt protein
(Figure 5D, right panel). Notably, the efﬁciency of
miRISC displacement from HBS_50_MBSb was much
higher than that seen with HBS_50_MBSp containing a
perfectly complementary let-7 site. This difference was
also apparent when the effect of HuR on miRISC associ-
ation with both substrates was compared in the same
experiment (data not shown).
Figure 5. HuR promotes dissociation of miRISC from target RNAs bearing either perfectly complementary or bulged let-7 sites.
(A) Characterization of puriﬁed miRISC complexes containing Ago1, Ago2 or indicated Ago2 mutants. (Left panel) Western blot performed
with anti-HA antibody, showing puriﬁcation of miRISCs containing Ago1, Ago2 or indicated Ago2 mutants. ‘I’ denotes input cell extracts and
‘P’ denotes miRISCs puriﬁed on anti-FLAG M2 Afﬁnity beads. (Right panel) miRISC cleavage assay demonstrating that only miRISC containing wt
Ago2 is catalytically active. ‘Inp’ denotes input 50-32P-labeled RNA substrate HBS_50_MBSp. (B) Schematic overview of experiments to determine
the effect of HuR on association of miRISC with target RNA. MiRISC-bound beads were incubated with target RNA for 15min at 23C followed
by additional 15min incubation at 23C in the absence (control) or presence of 150 nM HuR. The RNA remaining bound to beads was subjected to
RT-qPCR (for details see ‘Materials and Methods’ section). (C) Quantiﬁcation, by RT-qPCR, of the effect of HuR on association of indicated
different forms (Ago2, Ago1, Ago2D669A and Ago2H634A) of miRISC with HBS_50_MBSp RNA. Values for RNA remaining bound with different
miRISC forms upon addition of 150 nM HuR are normalized to values measured in the absence of HuR which are set to 1 (means±SD; n 3)
(D) (Right panel) Quantiﬁcation, by qRT-PCR, of the effect of HuR or HuRH3 mutant on association of indicated forms (Ago2, Ago1 and
Ago2D669A) of miRISC with RNA targets bearing bulged let-7 site positioned either downstream (HBS_50_MBSb) or upstream (MBSb_50_HBS)
of the HuR binding site. Values for RNA remaining bound with different miRISC forms upon addition of 150 nM HuR or HuRH3 are normalized
to values measured in the absence of HuR (means±SD; n 3). (Left panel) Schemes of target RNAs used for the assay. ‘b’ denotes the bulged site.
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Taken together, these results indicate that HuR
promotes dissociation of miRISC from substrates contain-
ing both perfectly complementary and bulged miRNA
sites and that the potential of HuR to oligomerize along
RNA is important for this effect.
HuR does not interact with miRISC proteins
The requirement for oligomerization described above
suggested that HuR has to get into proximity of
miRISC and possibly interact with its components to
exert its derepressive function. To address this possibility,
we tested whether HuR interacts with miRISC compo-
nents, such as Ago or GW182 proteins. We performed
immunoprecipitation (IP) experiments of HuR and Ago
proteins from cell extracts prepared from either stressed or
non-stressed cells. Use of antibodies against endogenous
proteins revealed that HuR did not co-immunoprecipitate
Ago2 and that Ago2 did not co-immunoprecipitate HuR
(Supplementary Figure S5A) in either type of cells. The IP
experiments with ectopically expressed epitope-tagged
proteins similarly provided no evidence of HuR interact-
ing with Ago2, Ago3 or protein TNRC6B (Supplementary
Figures S5B and S5C). As expected, the IP experi-
ments revealed interaction of Ago2 and TNRC6B
(Supplementary Figure S5B). We conclude that HuR
does not stably associate with miRISC protein
components (see ‘Discussion’ section).
Addition of HuR to Krebs ascites cell extract alleviated
deadenylation of an miRNA reporter
We previously described an in vitro extract derived from
Krebs-2 ascites cells that faithfully recapitulates both
RNA deadenylation and translational repression induced
by miRNAs (52,53). We tested whether addition of
recombinant HuR or its mutants interferes with the
miRNA-induced deadenylation of RNA bearing let-7
miRNA sites and the HuR binding region ARD, derived
from the CAT-1 30-UTR [6xB-ARD-30-UTR; for detailed
description of ARD, see ref. (11)]. We found that addition
of wt HuR or its mutants HuRH and HuR3, which
have the potential to relieve repression in other assays
(see above), markedly inhibited deadenylation of
6xB-ARD-30-UTR RNA in vitro. In contrast, addition
of the HuR mutant HuRH3 that was inactive in the
derepression had no effect (Figures 6A, upper row and
6B, left panel). In control experiments, we veriﬁed
that addition of any of the four forms of HuR had no
major effect on deadenylation of RNA containing no
ARD (6xB-30-UTR; Figures 6A, second row and
6B, right panel). As expected, addition of anti-let-7
20–O-methyl oligonucleotide blocked deadenylation of
6xB-ARD-30-UTR and RNA bearing mutated let-7 sites
(6xBMut-ARD-30-UTR) did not undergo deadenylation
(Figure 6A, two bottom panels).
In conclusion, HuR can interfere with the inhibitory
function of let-7 in the in vitro system recapitulating
miRNA-mediated deadenylation. Similarly, as in the
case of assays involving puriﬁed miRISC (Figure 2C and
D), the presence of either the HuR hinge region or the
RRM3 was required for the protein to counter the let-7
induced mRNA deadenylation, consistent with the possi-
bility that the HuR effect involves its oligomerization.
DISCUSSION
We showed previously that both CAT-1 mRNA and
reporter mRNAs bearing AREs in their 30-UTR can be
relieved of miRNA-mediated repression in mammalian
cells subjected to various stress conditions. The derepres-
sion required the binding of the ELAV family protein
HuR to the 30-UTR AREs, which occurred even when
AREs were positioned at a considerable distance from
the miRNA sites (11). These observations raised questions
about the mechanism of HuR action and that of other
possibly stress-induced factors that may participate in
the process. In this present report, we show that the
relief of miRNA-mediated repression involving HuR can
be recapitulated in different in vitro systems in the absence
of stress, indicating that HuR alone is sufﬁcient to exe-
cute derepression upon binding to the RNA ARE.
Nevertheless, it is possible that additional factors can
assist HuR in its activity in a cellular context. Using
in vitro assays with puriﬁed miRISC and recombinant
HuR and its mutants, we show that HuR leads to the
dissociation of miRISC from target RNA and that this
function of HuR correlates with its property to oligomer-
ize along RNA. Further, we demonstrate that HuR asso-
ciation with AREs can also inhibit miRNA-mediated
deadenylation of mRNA in the Krebs-2 ascites extract,
in a similar manner depending on the potential of HuR
to oligomerize.
Our ﬁndings that addition of HuR could interfere
with miRISC activity irrespective of whether the
miRISC site was located 20- or 50-nt away from the
HuR-binding region suggested that the HuR effect is
unlikely to be caused by direct sterical occlusion of the
miRISC site by the protein (Figure 1). Since HuR and
related proteins, such as HuD and Drosophila ELAV are
known to oligomerize along RNA substrates (35–40),
we investigated whether this property of HuR plays a
role in the suppressive effect of HuR on miRISC
activity. Three types of experiments provided strong
support for the multimerization of HuR being important:
(i) only full-length HuR and its mutants HuRH
and HuR3, all able to multimerize [Supplementary
Figure S3; and (36)], inhibited the miRISC-mediated
cleavage of RNA bearing HBS and MBS sequences. In
contrast, an HuR mutant (HuRH3) that is devoid of a
hinge and RRM3 and that binds target RNA but is
impaired in multimerization [Supplementary Figure S3;
and ref. (36)] did not interfere with miRISC activity
(Figure 2C and D). (ii) Pre-hybridization of target RNA
with oligonucleotides, either DNA or LNA, complemen-
tary to the spacer separating HBS and MBS sequences
eliminated its inhibitory effect on RNA cleavage by
miRISC (Figure 3B). (3) Finally, the full-length HuR
and its mutants able to oligomerize but not the mutant
HuRH3, which lacks a hinge and RRM3, interfered
with the let-7-induced mRNA deadenylation in vitro
5096 Nucleic Acids Research, 2012, Vol. 40, No. 11
(Figure 6), consistent with the possibility that this HuR
effect requires its oligomerization.
The apparent role of oligomerization in the derepressive
function of HuR suggested that the protein has to get into
proximity of miRISC to interfere with its activity.
Consistently, our results indicate that HuR may exert its
function by displacing the miRISC from RNA. This con-
clusion is supported by in vitro experiments performed
with puriﬁed HuR and let-7-enriched miRISC and
RNAs bearing both HuR and miRNA sites. These experi-
ments revealed that addition of HuR, either simul-
taneously with miRISC or after miRISC has been
pre-bound to RNA, results in a concentration-dependent
dislocation of miRISC from the target RNA (Figures 1, 4
and 5). This effect occurred irrespective of whether
miRISC was base paired with target RNA by perfect or
imperfect complementarity, although the HuR effect was
much more pronounced for substrates associating with
miRISC through an imperfect, central bulge-forming
interaction (Figure 5).
The less effective displacement of miRISC from a target
having perfect complementarity, and hence engaged in a
more stable interaction with let-7 miRNA, suggested that
one possible mode of HuR function is through the desta-
bilization of the miRNA–mRNA base pairing. This notion
is supported by our observation that, in transfected cells,
HuR does not alleviate repression induced by direct
tethering of Ago2 to mRNA, a process not involving
miRNA base pairing with the target RNA
(Bhattacharyya, S.N., Kundu, P. and Fillipowicz, W.;
unpublished results). The possibility that HuR functions
by displacing miRISC from the target, and not by
interfering with the repressive function of the miRISC
protein components, is also supported by the results of
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immunoprecipitation experiments. We found no evidence
that Ago or GW182 proteins interact with endogenous
HuR (Supplementary Figure S5). We note, however, that
some authors have reported that HuR, either endogenous
(17) or overexpressed (57), interacts in an RNA-dependent
manner with Ago2. In contrast, others did not detect
HuR–Ago2 interaction even in the absence of RNase treat-
ment (58), or did not ﬁnd HuR among proteins identiﬁed
by mass spectrometry as associated with tagged Ago1,
Ago2 or three human GW182 proteins, but found it in
complexes with Ago3 and Ago4 (59).
The HuR effect described in this study, leading to the
relief of miRNA repression from a distance in a process
likely involving HuR oligomerization, represents a novel
mechanism of miRNA regulation, differing from other
examples of the cross-talk between miRNAs and RBPs
at the 30-UTR of metazoan mRNAs. Dead end (Dnd1),
an RBP expressed in germ cells of zebraﬁsh and mammals,
prevents miRNA repression by binding to sequence
elements in the 30-UTR that overlap with miRNA sites,
thus effectively blocking miRNA access to target mRNA
(15). Similarly, hnRNP protein L competes with miRNA
for binding to the same CA-rich elements present in the
30-UTR of VEGFA mRNA (14), and the CRD-BP RBP
competes with miR-340 for binding to the MITF mRNA
30-UTR (60). In contrast, Pumilio 1 (PUM1), an
ubiquitously expressed RBP, was found to facilitate
miRNA repression. Binding of PUM1 to the p27
mRNA 30-UTR induces a local change in RNA structure
that favors association with speciﬁc miRNAs (16).
Regulation of miRNA repression by RBPs interacting
with the 30-UTR is probably a widespread phenomenon
(8,23,24). In addition to the examples discussed above,
further cases of cross-talk between RBPs and miRNAs
have been reported (13,18,61), although their mechanisms
are unknown. Furthermore, a comparative study of
mRNAs interacting with Pumilio (PUF) proteins showed
a considerable enrichment of PUF-binding sites in the
vicinity of predicted miRNA recognition sequences in
human mRNAs (62), suggesting that PUF-miRNA
cross-talk is a common event. Importantly, several of
the mechanistically unsolved cases also involve HuR.
Gorospe and collaborators found that HuR antagonizes
the miR-548c-3p-mediated repression of topoisomerase
IIa (TOP2A) mRNA (21) and miR-494-mediated repres-
sion of nucleolin mRNA (22) in HeLa cells. Similarly, as
in the case of CAT-1 mRNA (11), interaction sites of HuR
and co-regulated miRNAs in both mRNAs were
positioned at a considerable distance, suggesting that the
mechanism of HuR effect might be related to that
reported in our study. Interestingly, in two other
examples involving HuR, the protein appeared to have a
positive rather than alleviating effect on miRNA-mediated
repression. Speciﬁcally, it was found that HuR enhances
c-Myc mRNA repression by let-7 (17) and RhoB mRNA
repression by miR-19 (12). Possibly, HuR can enhance
miRNA repression by locally modifying mRNA structure
and increasing the accessibility of miRNA-binding sites,
as was shown for PUM and p27 mRNA (16).
The HuR-miRNA cross-talk most probably extends far
beyond the examples described above. This is supported
by the results of recent transcriptome-wide mapping of
HuR binding sites in mammalian cells (63–65). These
studies revealed that HuR sites are enriched near predicted
miRNA sites in mRNAs and frequently overlap with
them. Mukherjee et al. (2011) demonstrated that func-
tional depletion of miRNAs in HeLa cells results in a
signiﬁcantly lower upregulation of mRNAs containing
overlapping miRNA and HuR sites when compared to
the mRNAs bearing no overlapping sites, suggesting
that the competition between HuR and miRNAs to
access the target sites can prevent miRNA repression.
However, these ﬁndings do not explain the ’long-distance’
alleviating effects of HuR observed in the case of CAT-1,
TOP2A and nucleolin mRNAs (11,21,22) and the
reporters used in this study.
It will be important to investigate which factors deter-
mine the outcome, either negative or positive, of the HuR
effect on miRNA repression. The activity of HuR is known
to be controlled by various post-translational modiﬁca-
tions and proteolytic cleavages, and also by interaction
with protein ligands (34). Moreover, HuR has recently
been reported to have an RNA 30-terminal adenosyl trans-
ferase activity, residing in RRM3 (66). Hence, it is perhaps
not surprising to ﬁnd that the protein contributes to
miRNA regulation in different ways.
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